Literature DB >> 1827421

Dominant and recessive mutations define functional domains of Toll, a transmembrane protein required for dorsal-ventral polarity in the Drosophila embryo.

D S Schneider1, K L Hudson, T Y Lin, K V Anderson.   

Abstract

The asymmetry of the dorsal-ventral pattern of the Drosophila embryo appears to depend on the ventral activation of the transmembrane Toll protein. The Toll protein is found around the entire dorsal-ventral circumference of the embryo, and it appears to act as a receptor for a ventral, extracellular signal and to then relay that signal to the cytoplasm in ventral regions of the embryo. Three of five recessive loss-of-function alleles of Toll are caused by point mutations in the region of the cytoplasmic domain of Toll that is similar to the mammalian interleukin-1 receptor, supporting the hypothesis that Toll acts as a signal-transducing receptor. Nine dominant gain-of-function alleles that cause Toll to be active in dorsal, as well as ventral, regions of the embryo are caused by mutations in the extracellular domain. Three of the dominant alleles appear to cause the protein to be constitutively active and are caused by cysteine-to-tyrosine changes immediately outside the transmembrane domain. All six of the remaining dominant alleles require the presence of a wild-type transmembrane Toll protein for their ventralizing effect and all encode truncated proteins that lack the transmembrane and cytoplasmic domains.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1827421     DOI: 10.1101/gad.5.5.797

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  88 in total

1.  members only encodes a Drosophila nucleoporin required for rel protein import and immune response activation.

Authors:  A E Uv; P Roth; N Xylourgidis; A Wickberg; R Cantera; C Samakovlis
Journal:  Genes Dev       Date:  2000-08-01       Impact factor: 11.361

2.  The Drosophila Toll-9 activates a constitutive antimicrobial defense.

Authors:  James Y Ooi; Yoshimasa Yagi; Xiaodi Hu; Y Tony Ip
Journal:  EMBO Rep       Date:  2001-12-19       Impact factor: 8.807

3.  An anteroposterior Dorsal gradient in the Drosophila embryo.

Authors:  A M Huang; J Rusch; M Levine
Journal:  Genes Dev       Date:  1997-08-01       Impact factor: 11.361

4.  Transcriptional repression via antilooping in the Drosophila embryo.

Authors:  Vivek S Chopra; Nikki Kong; Michael Levine
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-29       Impact factor: 11.205

Review 5.  Mucins and toll-like receptors: kith and kin in infection and cancer.

Authors:  Shikha Tarang; Sushil Kumar; Surinder K Batra
Journal:  Cancer Lett       Date:  2012-02-03       Impact factor: 8.679

6.  Genetic characterization of two gain-of-function alleles of the effector caspase DrICE in Drosophila.

Authors:  Y Wu; J L Lindblad; J Garnett; H E Kamber Kaya; D Xu; Y Zhao; E R Flores; J Hardy; A Bergmann
Journal:  Cell Death Differ       Date:  2015-11-06       Impact factor: 15.828

7.  RNA polymerase stalling at developmental control genes in the Drosophila melanogaster embryo.

Authors:  Julia Zeitlinger; Alexander Stark; Manolis Kellis; Joung-Woo Hong; Sergei Nechaev; Karen Adelman; Michael Levine; Richard A Young
Journal:  Nat Genet       Date:  2007-11-11       Impact factor: 38.330

8.  Cytokine Spatzle binds to the Drosophila immunoreceptor Toll with a neurotrophin-like specificity and couples receptor activation.

Authors:  Miranda Lewis; Christopher J Arnot; Helen Beeston; Airlie McCoy; Alison E Ashcroft; Nicholas J Gay; Monique Gangloff
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-26       Impact factor: 11.205

9.  Common interaction surfaces of the toll-like receptor 4 cytoplasmic domain stimulate multiple nuclear targets.

Authors:  Tapani Ronni; Vishal Agarwal; Michael Haykinson; Margaret E Haberland; Genhong Cheng; Stephen T Smale
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

10.  Drosophila MyD88 is an adapter in the Toll signaling pathway.

Authors:  T Horng; R Medzhitov
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-16       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.